Valneva's half-year loss narrows on strong travel vaccine demand

Sept 21 (Reuters) - French vaccine maker Valneva VLS.PA on Thursday reported a smaller half-year loss, as a rebound in global tourism boosted sales of its travel vaccines Ixiario and Dukoral. The ... Read More

Lyft: Q1 Loss Narrows as Bookings Climb | Business Travel News

Lyft reported first-quarter revenue of nearly $1.3 billion, up about 27.7 percent year over year, with gross bookings of about $3.7 billion, up 21.1 percent from a year prior. The company’s net loss ... Read More

Lufthansa Adjusted Loss Narrows as Revenue Rises Amid Strong Travel Demand - WSJ - The Wall Street Journal

Deutsche Lufthansa LHA1.87%increase; green up pointing triangle said demand for air travel remained strong and that second-quarter ticket sales for flights to and from North America were up on ... Read More

Valneva Reports Half Year 2023 Financial Results and Provides Corporate Updates

Saint-Herblain (France), September 21, 2023 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today reported its consolidated financial results for the first half of ... Read More

Rebound in travel helps vaccine maker Valneva post smaller-than-expected loss - Reuters

French vaccine maker Valneva reported on Thursday a smaller-than-expected first-quarter loss as sales of travel vaccines Dukoral and Ixiaro improved, propelling its shares 16% up. Read More

Valneva's half-year loss narrows on strong travel vaccine demand - AOL

(Reuters) -French vaccine maker Valneva on Thursday reported a smaller half-year loss, as a rebound in global tourism boosted sales of its travel vaccines Ixiario and Dukoral. The group's net loss ... Read More

Lufthansa Adjusted Loss Narrows as Revenue Rises Amid Strong Travel Demand

Demand in the U.S. continued to rise and the group flew around 25% more passengers from the U.S. to Europe in March than it had a year prior, the company said. Read More

Valneva Reports Half Year 2024 Financial Results and Provides Corporate Updates

VALNEVA. First-Half Sales Performance in Line with Full-Year 2024 Guidance. Total revenues of €70.8 million, including product sales of €68.3 million, in line with anticipated supply and sales ... Read More

Valneva's half-year loss narrows on strong travel vaccine demand By Reuters - Investing.com UK

(Reuters) -French vaccine maker Valneva on Thursday reported a smaller half-year loss, as a rebound in global tourism boosted sales of its travel vaccines Ixiario and Dukoral. The group's net loss ... Read More